Immunovant, Inc.
Immunovant, Inc.（IMVT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
imvt · 股价预测 · 23 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 23 位华尔街分析师
Buy
23 位分析师
共识
评级分布
12 个月目标价
High
$50.00
Consensus
$43.67
+40.4% upside
Low
$40.00
Median: $41 · Last Close: $31.11
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$43.67
40.4% upside
High Target
$50
60.7%
Low Target
$40
28.6%
Current Price
$31.11
as of today
Based on analyst price targets, the IMVT stock price prediction for the next 12 months ranges from $40 to $50. The consensus IMVT price forecast of $43.67 implies 40.4% upside from the current price of $31.11.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $31.24 | ↑ 0.45% |
1-day model range: $30.83–$31.65. Peak: $31.65 (+0.45%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | -30.5% |
| 2028 | $18 | -43.2% |
| 2029 | $16 | -49.4% |
| 2030 | $15 | -52.7% |
| 2031 | — | -54.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMVT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-22 | Truist Securities | Maintains | Hold→Hold |
| 2026-05-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-21 | B of A Securities | Maintains | Buy→Buy |
| 2026-04-15 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-08 | Truist Securities | Maintains | Hold→Hold |
| 2026-01-06 | Wolfe Research | Upgrade ↑ | Peer Perform→Outperform |
| 2025-12-15 | Goldman Sachs | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Immunovant, Inc. (IMVT) stock. Of the recent 112 rating actions, 5 were upgrades and 6 were downgrades. 23 analysts currently cover IMVT.
分析师推荐趋势
IMVT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$7M
↓ 98.5% YoY
Revenue Next Year
$85M
↑ 1183.6% YoY
EPS This Year
$-2.62
EPS Next Year
$-2.54
↓ 3.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMVT EPS of $-2.62 for the current fiscal year, based on estimates from 9 analysts. The IMVT revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMVT 股价预测由两类独立数据源支撑：来自 23 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IMVT 的共识目标价为 $43.67（+40.4% 上行空间），分析师共识为 Buy。
IMVT 的短期预测（明日）为 $31.24（+0.45%）。 IMVT 对 2027 年的股价预测均值为 $22。 IMVT 对 2030 年的预测区间为 $13–$17。
Immunovant, Inc. 在 NASDAQ 上市，代码 IMVT。IMVT 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
IMVT 预测 · 8 个问题根据 23 位华尔街分析师，IMVT 的 12 个月平均目标价为 $43.67，最高 $50.00、最低 $40.00。若有图表，中位目标价可在上方查看。相对当前价 $31.11，隐含约 +40.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.